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Abstract
Tumor lysis syndrome is an oncologic emergency that usually occurs after chemotherapy in
patients with hematologic malignancies. Tumor lysis syndrome is rare in cases of solid tumors, especially when it occurs spontaneously. Herein, we present a case of spontaneous
tumor lysis syndrome in a 55-year-old woman who presented with dyspnea and was found
to have extensive metastatic small cell lung cancer. She developed acute oliguric renal failure
and multiple electrolyte abnormalities requiring hemodialysis. The findings of this case suggest that clinicians should maintain a high index of suspicion for patients with malignancies
who demonstrate the classic symptom of laboratory abnormalities even in the absence of
chemotherapy.
© 2017 The Author(s)
Published by S. Karger AG, Basel

Introduction

Tumor lysis syndrome (TLS) is an oncologic emergency that frequently occurs in patients with a rapidly proliferating malignancy, commonly hematologic, after the initiation of
cytotoxic therapy [1]. TLS is characterized by a massive release of intracellular potassium,
phosphate, and nucleic acid metabolites into the systemic circulation, which can result in
cardiac arrhythmia, seizure, or acute renal failure, all of which could be life-threatening.
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Prompt recognition and intervention is therefore important to prevent further complications [2]. However, spontaneous lysis of solid tumors is considered rare. Herein, we present
a case of spontaneous TLS in a 55-year-old woman that occurred shortly after she was diagnosed with metastatic small cell lung cancer.
Case Presentation

A 55-year-old female smoker with a history of chronic obstructive pulmonary disease
and diabetes presented to the emergency department with worsening dyspnea and respiratory distress. Her vital signs were significant for tachypnea and tachycardia. A physical examination revealed wheezing and decreased breath sounds in the left upper lung field. Chest
radiography showed left upper lung airspace disease. The initial presentation prompted the
diagnosis of pneumonia with acute respiratory failure. She was admitted to the intensive
care unit and started receiving intravenous antibiotics, fluid resuscitation, and noninvasive
ventilatory support. Owing to right upper quadrant pain and a high alkaline phosphate level,
abdominal ultrasonography was conducted, which showed an enlarged liver with multiple
masses. Once the patient’s condition stabilized, chest and abdomen computed tomography
examinations were performed, which showed a 7-cm mass in the left upper lung lobe associated with obstructive pneumonitis involving much of the left upper lobe (Fig. 1) as well as
extensive bilateral mediastinal and left hilar, axillary, and supraclavicular lymphadenopathy
and multiple liver metastases. Histopathologic examination of a liver biopsy specimen indicated high-grade small cell neuroendocrine cancer. Magnetic resonance imaging of the brain
yielded normal findings. Finally, the diagnosis was established as extensive stage small cell
lung cancer.
On hospital day 4, however, oliguria was detected. Serum biochemistry tests showed elevated creatinine and potassium levels, and therefore, sepsis-associated acute kidney injury
was initially considered. Subsequent laboratory examinations revealed increasing levels of
potassium (maximum 5.6 mEq/L), phosphorus (maximum 8.4 mg/dL), and uric acid (maximum 11.3 mg/dL). Accordingly, spontaneous TLS was diagnosed on the basis of the characteristic symptom of multiple electrolyte-related abnormalities. Aggressive treatment in the
form of fluid resuscitation, phosphate binders, allopurinol, and rasburicase was initiated.
Nonetheless, her renal function continued to deteriorate, with the creatinine level increasing
from 0.5 mg/dL upon admission to 7.9 mg/dL over 6 days. The departments of oncology and
nephrology were consulted, and the consensus was to conduct daily hemolysis after the first
cycle of palliative chemotherapy comprising cisplatin and etoposide. No major complications
were reported thereafter. However, her renal recovery was poor and she became dialysis
dependent.
Discussion

The patient in this case demonstrated spontaneous TLS caused by small cell lung cancer,
which is a highly proliferative solid tumor. The patient had oliguric renal failure and characteristic laboratory abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia in the setting of widespread metastatic disease. To the best of our knowledge, only
4 case reports of spontaneous TLS associated with small cell lung cancer have been reported
in the literature [3–6].
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Typically, TLS results from the massive release of intracellular electrolytes and metabolites when large numbers of tumor cells are lysed by cytotoxic chemotherapy or, rarely,
spontaneously. Most commonly, TLS occurs in cases of rapidly growing malignancies with a
high tumor burden, especially hematologic malignancies such as Burkitt lymphoma or acute
lymphoblastic leukemia [1]. However, cases of TLS involving solid tumors have been reported in the literature [7, 8]. The classic findings of TLS are hyperkalemia, hyperphosphatemia
with secondary hypocalcemia, and hyperuricemia. These electrolyte abnormalities can lead
to cardiac arrhythmia, seizure, or acute renal failure, all of which could be life-threatening
without prompt recognition and treatment.
The risk factors for TLS include bulky tumors, extensive metastatic diseases including
visceral or bone marrow involvement, elevated serum uric acid or lactate dehydrogenase
levels, high white blood cell count (>50,000 cells/µL), tumors with a high sensitivity to
antineoplastic treatment, and underlying renal dysfunction [7]. TLS involving solid tumors is
assumed to share similar risk factors [8, 9], although its spontaneous occurrence in tumor
types with relatively low response rates to cytotoxic therapy or without the classic rapid
growth kinetics [7], such as that observed in hepatocellular [10], pancreatic [11], ovarian
cancer [12], and malignant melanoma [13], has been reported. In our patient, the risk factors
included extensive metastatic disease and small cell lung cancer, a rapidly proliferative tumor cell type.
Although rare, TLS involving solid tumors is associated with a higher mortality rate than
that reported for hematologic malignancies [7]. Current guidelines emphasize both preventive measures and monitoring for high-risk patients undergoing chemotherapy [1, 2]. Aggressive fluid resuscitation to maintain a large urine output remains the mainstay of management. Allopurinol, a xanthine oxidase inhibitor, or rasburicase can be used to lower the
serum uric acid level. However, the utility of urine alkalization remains controversial. Hemodialysis is an option for patients who develop severe renal failure or refractory electrolyte abnormalities, as in our patient.
In conclusion, spontaneous TLS should be considered in the differential diagnosis for patients who demonstrate the classic electrolyte abnormalities or renal failure in the setting of
malignancy even without cytotoxic treatment, as observed in our case. Prophylactic treatment could be a suitable option for patients with multiple risk factors for spontaneous TLS.
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Fig. 1. Chest computed tomography image showing a left upper lung mass associated with obstructive

pneumonitis involving much of the left upper lobe.
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